American Oncology Network Inc. Reports Over 40% Revenue Growth, Surpassing $2 Billion for 12 Months Ending June 30, 2025

Reuters
08/12
<a href="https://laohu8.com/S/AONC">American Oncology Network</a> Inc. Reports Over 40% Revenue Growth, Surpassing $2 Billion for 12 Months Ending June 30, 2025

American Oncology Network Inc. $(AON)$ has reported strong financial results for the 12 months ended June 30, 2025, with annual revenue surpassing $2 billion. This represents a growth of over 40% compared to the previous 12-month period ending June 30, 2024. The increase in revenue is attributed to both organic expansion and the integration of new practices and providers in various markets. AON's provider network has expanded to over 300 oncology and hematology providers across 20 states, enhancing access to advanced treatment options. In terms of business operations, AON continues to invite new partners to join its network, promoting clinical autonomy and increased revenue through access to its comprehensive support infrastructure. Partner practices have experienced an average of more than 30% increase in sustainable income after joining AON. Looking forward, AON has shown leadership in value-based care by achieving nearly $6 million in cost savings for CMS and partnering with a multi-state commercial value-based care organization, resulting in $2.7 million in cumulative savings. Additionally, AON launched a self-funded employer contracting initiative covering 1 million lives, aligned with value-based benefit design principles, and implemented a social risk navigation platform that improved social risk factors by 39%, contributing to better health outcomes.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. American Oncology Network Inc. published the original content used to generate this news brief on August 12, 2025, and is solely responsible for the information contained therein.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10